Search results (60)
« Back to NewsMental health in the SME community
9 October 2022
Starting up your own business is challenging at the best of times; business plans, funding, licensing and IP are just a few of the hurdles founders face. In addition to the global pandemic and the current financial crisis in the UK, SMEs are under more pressure than ever.
The BioEscalator bids farewell to Nucleome Therapeutics
26 September 2022
Nucleome Therapeutics has outgrown its space at the BioEscalator and moved to pastures new. The company will continue its growth journey at The Oxford Science Park.
PepGen graduates from the BioEscalator
31 July 2022
PepGen is the last of the original cohort of companies that moved into the BioEscalator when it first opened. The new PepGen headquarters in Boston, USA, will manage late-stage preclinical testing and clinical and regulatory functions.
BioEscalator Pitch Battle 2022
11 July 2022
Infinitopes win the battle with an excellent presentation from CEO Jonathan Kwok on how the company is pushing the boundaries of science and medicine to identify hidden tumour targets to create high-efficiency vaccines.
The BioEscalator holds its first mini supplier show
10 July 2022
The show hosted four laboratory equipment and services companies: Olink, Stemcell, Analytik-Jena UK, and Tecan.
Fun in the sun at BioEscalator's Party in the Park
6 July 2022
The BioEscalator team and resident companies made their way to South Park, Oxford, today to enjoy well-deserved downtime at the BioEscalator's first Party in the Park.
Introducing Theraport
30 June 2022
Winner of OUBT's Biohackathon 2022, part of the Oxford Catalyse Programme, Theraport join the BioEscalator community for three months.
Introducing Oxford Cancer Analytics
21 June 2022
OXcan, short for Oxford Cancer Analytics, uses machine learning techniques combined with cutting-edge liquid biopsy techniques, to search for stage one lung cancer biomarkers.
Introducing Evolvere Biosciences
12 June 2022
A platform to develop biologic therapeutics that outsmart the evolution of antibiotic resistance to save millions of lives.
Tours and tenant talks at the BioEscalator open afternoon
24 May 2022
The event's purpose was to raise awareness of the BioEscalator and showcase the incredible science happening within its walls.
CyanoCapture moves on from the BioEscalator
15 May 2022
The company has moved into the newly refurbished Hayakawa Building at the Oxford Science Park.
BioEscalator sponsors Oxford Catalyse Programme 2022
1 February 2022
The BioEscalator is sponsoring a prize for the Biohackaton 2022, where teams created during the Oxford Catalyse 2022 programme will pitch their final business plans to a panel of judges.
BioEscalator opens new laboratory
1 February 2022
In December 2021, the BioEscalator opened a brand-new 137m2 laboratory, providing much-needed additional incubator space for Oxford-based start-ups.
Introducing Alethiomics
1 February 2022
Alethiomics Ltd is a pre-clinical biotech company harnessing the power of single cell multiomic technology to discover and develop life-changing treatments for patients with blood cancer.
Introducing CyanoCapture
15 November 2021
CyanoCapture aims for scalable, low-cost, biological carbon capture using genetically-modified algae, known as cyanobacteria.
Introducing Kyttaro
1 November 2021
Kyttaro is developing innovative therapeutics to treat hypertriglyceridemia, atherosclerotic cardiovascular disease and inflammatory and neurogastroenterology conditions.
Oxford BioEscalator celebrates three years of innovation
31 August 2021
The BioEscalator concept was born out of a shared need by academic researchers and their bioscience company collaborators for start-up incubator space close to academic labs. The vision was to develop a leading international centre for innovative bioscience with the potential to make a significant impact on healthcare. The incubator provides spin-outs and start-ups with laboratory and business support, enabling them to grow into leading bioscience ventures.
BioEscalator companies attract record funding as investors switch-on to biotech
17 August 2021
Despite the disruption caused by the pandemic, BioEscalator companies attracted a record high of £1.2B investment. This is part of a trend that saw investors attracted to the resilience displayed by the life science industry to the pandemic relative to other sectors.
BioEscalator Pitch Battle 2021
8 June 2021
PepGen wins the BioEscalator Pitch Battle 2021 with an excellent pitch on how the company is harnessing the power of its Enhanced Delivery Peptide technology to solve the drug-delivery challenge and realize the clinical potential of oligonucleotide therapies to transform the lives of people living with neuromuscular diseases.
The BioEscalator officially launches
18 June 2019
Baroness Nicola Blackwood of North Oxford, Parliamentary Under Secretary of State for Innovation, has officially opened the Oxford BioEscalator.